[go: up one dir, main page]

BRPI0909763A2 - soluções oftálmicas tamponadas com fosfato que apresentam eficácia otimizada - Google Patents

soluções oftálmicas tamponadas com fosfato que apresentam eficácia otimizada

Info

Publication number
BRPI0909763A2
BRPI0909763A2 BRPI0909763A BRPI0909763A BRPI0909763A2 BR PI0909763 A2 BRPI0909763 A2 BR PI0909763A2 BR PI0909763 A BRPI0909763 A BR PI0909763A BR PI0909763 A BRPI0909763 A BR PI0909763A BR PI0909763 A2 BRPI0909763 A2 BR PI0909763A2
Authority
BR
Brazil
Prior art keywords
phosphate buffered
ophthalmic solutions
optimal efficacy
exhibit optimal
buffered ophthalmic
Prior art date
Application number
BRPI0909763A
Other languages
English (en)
Inventor
Gary L Collins
Marcie Hargiss
Mark Lada
Robert T Mckee
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of BRPI0909763A2 publication Critical patent/BRPI0909763A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124—Hydrogen peroxide; Peroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A61L12/145—Polymeric quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0909763A 2008-03-19 2009-03-09 soluções oftálmicas tamponadas com fosfato que apresentam eficácia otimizada BRPI0909763A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3789408P 2008-03-19 2008-03-19
US12/399,681 US20090239954A1 (en) 2008-03-19 2009-03-06 Phosphate buffered ophthalmic solutions displaying improved efficacy
PCT/US2009/001495 WO2009117056A1 (en) 2008-03-19 2009-03-09 Phosphate buffered ophthalmic solutions displaying improved efficacy

Publications (1)

Publication Number Publication Date
BRPI0909763A2 true BRPI0909763A2 (pt) 2015-10-06

Family

ID=41089519

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0909763A BRPI0909763A2 (pt) 2008-03-19 2009-03-09 soluções oftálmicas tamponadas com fosfato que apresentam eficácia otimizada
BRPI0909000-2A BRPI0909000A2 (pt) 2008-03-19 2009-03-09 Soluções oftálmicas que apresentam eficácia otimizada

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0909000-2A BRPI0909000A2 (pt) 2008-03-19 2009-03-09 Soluções oftálmicas que apresentam eficácia otimizada

Country Status (12)

Country Link
US (2) US20090239775A1 (pt)
EP (2) EP2276462A1 (pt)
JP (2) JP2011515394A (pt)
KR (2) KR20100126512A (pt)
CN (2) CN101977590A (pt)
AR (2) AR070999A1 (pt)
AU (2) AU2009226113A1 (pt)
BR (2) BRPI0909763A2 (pt)
CA (2) CA2718864A1 (pt)
RU (2) RU2010142462A (pt)
TW (2) TW200950822A (pt)
WO (2) WO2009117057A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
CN102802677B (zh) 2009-06-29 2014-12-24 美你康株式会社 隐形眼镜的消毒系统
TW201127423A (en) * 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
JP2011251932A (ja) * 2010-06-01 2011-12-15 Mandom Corp 点眼剤及び洗眼剤
HK1200113A1 (en) * 2012-02-27 2015-07-31 日本乐敦制药株式会社 Ophthalmic composition
US20160074321A1 (en) * 2013-03-27 2016-03-17 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
WO2014190141A1 (en) * 2013-05-23 2014-11-27 Stone Ralph P Scleral lens solution
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
JP7490570B2 (ja) 2018-04-27 2024-05-27 アラーガン、インコーポレイテッド 抗微生物有効性の増強及び毒性の減少を有する亜塩素酸ナトリウム組成物
CN114318343A (zh) * 2020-09-29 2022-04-12 上海飞凯材料科技股份有限公司 一种蚀刻液及其应用
TW202434214A (zh) * 2022-12-21 2024-09-01 美商壯生和壯生視覺關懷公司 眼科裝置之組成物(二)
TW202439971A (zh) * 2022-12-21 2024-10-16 美商壯生和壯生視覺關懷公司 眼科裝置之組成物
WO2024134384A1 (en) * 2022-12-21 2024-06-27 Johnson & Johnson Vision Care, Inc. Compositions for ophthalmologic devices

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
US5145643A (en) * 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5451398A (en) * 1990-01-05 1995-09-19 Allergan, Inc. Ophthalmic and disinfecting compositions and methods for preserving and using same
US5277901A (en) * 1990-01-05 1994-01-11 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5019380A (en) * 1990-04-27 1991-05-28 Bausch & Lomb Incorporated Novel antimicrobial compositions and process for preparing the same
US5523012A (en) * 1991-07-19 1996-06-04 Ciba-Geigy Corporation Hydrogen peroxide disinfection solutions
DE4132259A1 (de) * 1991-09-27 1993-04-01 Wild Heerbrugg Ag Ueberstrahlungsschutz fuer ein nachtsichtgeraet
US5356555A (en) * 1992-09-14 1994-10-18 Allergan, Inc. Non-oxidative method and composition for simultaneously cleaning and disinfecting contact lenses using a protease with a disinfectant
ES2199956T3 (es) * 1992-12-17 2004-03-01 Advanced Medical Optics, Inc. Solucion desinfectante de lentes de contacto que contiene un agente oxidante y polivinilpirrolidona.
US5648074A (en) * 1993-05-25 1997-07-15 Allergan Compositions and methods for disinfecting contact lenses and reducing proteinaceous deposit formation
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
JP2839819B2 (ja) * 1993-05-28 1998-12-16 株式会社東芝 不揮発性半導体記憶装置
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US6024954A (en) * 1994-12-12 2000-02-15 Allergan Compositions and methods for disinfecting contact lenses and preserving contact lens care products
FR2751634B1 (fr) * 1996-07-29 1998-09-11 Essilor Int Solution stabilisee et tamponnee de peroxyde d'hydrogene, son procede de fabrication et son utilisation a la decontamination de lentilles de contact
US5746972A (en) * 1996-11-01 1998-05-05 Allergan Compositions and methods for disinfecting and cleaning contact lenses
ATE289804T1 (de) * 1998-10-08 2005-03-15 Hampar L Karagoezian Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten
WO2000026334A1 (en) * 1998-10-30 2000-05-11 Metrex Research Corporation Simultaneous cleaning and decontaminating compositions and methods
US6309596B1 (en) * 1998-12-15 2001-10-30 Bausch & Lomb Incorporated Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US20070104798A1 (en) * 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
AU2001293851A1 (en) * 2000-09-28 2002-04-08 Novartis Ag Stabilized hydrogen peroxide solutions
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20050244509A1 (en) * 2004-03-17 2005-11-03 Fu-Pao Tsao Ophthalmic solutions
BRPI0709549A2 (pt) * 2006-03-17 2011-07-19 Johnson & Johnson Vision Care métodos para estabilizar composições instáveis oxidativamente
US20090004288A1 (en) * 2007-06-29 2009-01-01 Collins Gary L Stabilized ophthalmic solutions

Also Published As

Publication number Publication date
RU2010142488A (ru) 2012-04-27
BRPI0909000A2 (pt) 2015-08-04
JP2011515394A (ja) 2011-05-19
WO2009117056A1 (en) 2009-09-24
CA2718864A1 (en) 2009-09-24
CA2718866A1 (en) 2009-09-24
EP2276462A1 (en) 2011-01-26
AR070999A1 (es) 2010-05-19
RU2010142462A (ru) 2012-04-27
AR071001A1 (es) 2010-05-19
AU2009226112A1 (en) 2009-09-24
KR20100135813A (ko) 2010-12-27
TW201000149A (en) 2010-01-01
AU2009226113A1 (en) 2009-09-24
JP2011515393A (ja) 2011-05-19
TW200950822A (en) 2009-12-16
US20090239775A1 (en) 2009-09-24
CN101977590A (zh) 2011-02-16
EP2271313A1 (en) 2011-01-12
KR20100126512A (ko) 2010-12-01
WO2009117057A1 (en) 2009-09-24
CN101977591A (zh) 2011-02-16
US20090239954A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
BRPI0909763A2 (pt) soluções oftálmicas tamponadas com fosfato que apresentam eficácia otimizada
BRPI0906480A2 (pt) Isolador com amortecimento
EP2115519A4 (en) DYNAMIC OPHTHALMIC OPENING
BRPI0907569A2 (pt) Isolador de desacoplamento
BRPI0908678A2 (pt) dispositivo de retenção de artigos oculares
EP2307845A4 (en) LOCK HOLSTER
BRPI0921327A2 (pt) Combinação de herbicida-protetor
PT2813570T (pt) Resumo
BRPI0912271A2 (pt) co-autoria estruturada
DK2331687T3 (da) Antimikrobielle midler
EP2170232A4 (en) LASER FOR REJUVENATING THE NETWORK SKIN
BRPI0906706A2 (pt) Conjuntos de válvulas
PT3045471T (pt) Resumo
ATE518975T1 (de) Lyocellfaser
DE112009000964A5 (de) Tampon
FI20085782A0 (fi) Kartonkikone
EP2256192A4 (en) CATALASE WITH TEMPERATURE TOLERANCE
BRPI0911492A2 (pt) transações seguras com base na web
BRPI0921856A2 (pt) valvula de alívio
DE112008002581A5 (de) Antriebsstrang
DE112007003038A5 (de) Antriebsstrang
BRPI0920208A2 (pt) Agentes rodenticidas sinergísticos
BRPI0909287A2 (pt) Retenção
BRPI0922023A2 (pt) unidade de amortecimento para um eixo
DK2381543T3 (da) Fiberlaserapparat

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.